As the Gut Doctor podcast continues to raise awareness for colorectal cancer, Dr. Parikh interviews Dr. Paul Limburg, MD, who is a gastroenterologist and chief medical officer for Exact Sciences. They discuss colon cancer prevalence, barriers to CRC screening, and the role of stool based testing such as Cologuard. 

This episode is sponsored by Exact Sciences whose purpose is to help eradicate cancer by preventing it, detecting it earlier, and guiding personalized treatment. Exact Sciences is the maker of the Cologuard® test, a stool-based screening test for average risk adults ages 45 and over. 

As we continue to raise colon cancer awareness in the month of March, in this GI 101 episode, Dr. Parikh interviews Dr. Larry Kogan to discuss the basics of a colonoscopy. What is a colonoscopy? How do we do it? Why do we do it? Dr. Kogan is a third year gastroenterology fellow at Yale University. The GI 101 series is a set of episodes focused on interviewing physicians in training to get their perspective on bread and butter GI topics.

It is March so all our episodes focus on colorectal cancer! In today's episode, Dr. Toufic Kachaamy, Chief of Medicine and Director of Gastroenterology at City of Hope in Phoenix, discusses the new frontier of endoscopic oncology. He shares innovative insights on rectal cancer ablation, artificial intelligence for polyp detection, genomic testing for colon cancer and a new way to identify flat polyps that he has recently patented. His core message: we must detect polyps early and prevent colon cancer.

In a Gut Doctor first, Dr. Parikh interviews a fellow podcaster- Amber Tresca! Amber is a medical writer, podcast host and blogger. Her platform, AboutIBD, empowers patients living with inflammatory bowel disease as she shares her experiences living with ulcerative colitis and a J-pouch. In this episode, she shares her journey and provides tips for patients living with IBD.

In the GI 101 series, Dr. Parikh interviews one of the training physicians to get their perspective on a variety of gastrointestinal topics. Today he interviews Dr. Hamza Sohail, a gastroenterology fellow at Baystate Health, and they discuss ascites. This episode is brought to you by Mindray & Aegle Medical, manufacturer and distributor of the Hepatus-series platform, which is a NexGen vibration-controlled elastography technology used to stage and monitor liver disease.

In this Gut Doctor episode, Dr. Parikh takes on the patient role as PA Sarah Enslin discusses diagnosis and management of Barrett's esophagus. Sarah Enslin is a physician assistant at the University of Rochester Medical Center and Vice Chair of American College of Gastroenterology's Advanced Practice Provider committee. Today’s episode is brought to you by Castle Biosciences, maker of TissueCypher, a test designed to predict the risk of esophageal cancer in patients with Barrett’s esophagus.

In this episode of the Gut Doctor podcast, Dr. Parikh interviews Dr. Ponni Perumalswami to discuss the spectrum of liver diseases caused by alcohol use and toxicity. Dr. Perumalswami is Professor of Medicine at the University of Michigan and the Director of the Alcohol Liver Disease program. She reviews the pathophysiology of alcoholic liver disease, signs and symptoms, and the range of treatment options including brief intervention therapy.

In this episode of the Innovation series, Dr. Parikh interviews Dr. Kosinski, founder of SonarMD. SonarMD uses digital health to perform monthly health checks, recognize early warning signs and prevent gut disease flare ups.  

What is endoscopic ultrasound? Dr. Ari Benson, interventional endoscopist and Chief of Endoscopy at Shaare Zedek Medical Center, tells patients what they need to know about EUS.

In today's episode of the Innovation series, Dr. Parikh sits down with Mindy Mintz Mordecai, president and CEO of the Esophageal Cancer Action Network (ECAN). They discuss Mindy's journey, the origins of ECAN, and how it continues to support current and future patients with esophageal cancer. Today's episode was brought to you by Castle Biosciences, maker of TissueCypher, a test designed to predict the risk of esophageal cancer in patients with Barrett's esophagus.